Method of treating irritable bowel syndrome with constipations

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to gastroenterology and represents a method of treating irritable bowel syndrome with constipations with using low-mineralised hydrocarbonate sodium mineral water "Alabakhskaya" (AMW) with a faintly alkaline reaction of the aqueous medium involving the daily three-time drinking of AMW, duodenal drainages with using AMW, intestinal irrigations with using AMW following cleansing enemas, taking toning pine or salt-water baths; the integrated therapeutic course makes 21 day, including an 18-day drinking therapy, a single drinking dose of AMW at temperature 36-38°C is gradually increased from 50-80 ml to 200 ml; the duodenal drainage is conducted with using AMW at temperature 37-39°C in the amount of 200 ml of a single dose; for intestinal irrigations, AMW is pre-heated to 39-40°C, while a single dose makes 500 ml to be gradually increased to 800 ml; the intestinal irrigations are alternated with taking baths.

EFFECT: invention provides higher clinical effectiveness and reduces the length of treatment of irritable bowel syndrome with constipations.

2 ex

 

The invention relates to medicine, namely to gastroenterology and balneology, in particular to methods for treating irritable bowel syndrome with constipation.

Known methods of treatment of drinking mineral waters chronic enteritis, colitis, irritable bowel syndrome (see Reference sanatorium-resort selection. Edited by Bogoliubov V.M., M.: Medicine, 1986; Medical rehabilitation. Edited by Bogoliubov V.M., Moscow-Perm, 1998; Grigoriev PA, A.V. Yakovenko, reference manual gastroenterology, M.: MIA, 1997, S; Kulikov A.G. //Physiotherapy and balneology. Book II. Ch.5. M., Izd-vo BINOM, 2008. - S-172).

There is a method of treatment of patients with irritable bowel syndrome (see EN NO. 2253465, AK 35/08, OR 1/00, 10.06.2005,), based on the use of bicarbonate-magnesium-calcium-sodium brackish mineral water "Amur-2". The method is used in the complex treatment of functional bowel pathologies and provides drinking mineral water "Amur-2" different temperatures depending on the availability in patients with diarrhea or constipation. However, the method does not involve the carrying out of the stage of adaptation to water treatment that may not contribute to increasing efficiency and reducing treatment time. Comprehensive treatment of mineral water "Amur-2" includes only HV the internal use of the data.

However, it is known that in the Central region of the Republic of Sakha (Yakutia), on-site Megino-Kangalassky region has a unique mineral waters and therapeutic muds soda lake "Abalach". Abelanski dirt included in the list of most significant used deposits of curative mud Russia (see guidelines of the Ministry of health of the Russian Federation No. 99/228 from 22.12.1999, List of resorts in Russia with the rationale for their unique natural and climatic factors", section 3).

Task to be solved by the claimed invention is directed, is expressed in the increase of efficiency and reduction of terms of treatment of irritable bowel syndrome with constipation.

The technical effect obtained by the solution of the problem, expressed in receiving treatment with complex external and internal use of mineral water Deposit Abalaka" (the Republic of Sakha (Yakutia)).

To solve this problem a method of treating irritable bowel syndrome with constipation using mineralized sodium bicarbonate mineral water "Abalaka (CA) with a slightly alkaline reaction of the aquatic environment is tailored to the nature of the violations of motor activity of the bowel and acid-forming function of the gastric mucosa and includes daily tehranbureau reception armature, duodenal drainage using CA, procedures, intestinal irrigation with the use of CA after enemas, procedures tonic coniferous or RPMA baths. This course is a comprehensive treatment is 21 days, including 2 days of inspection of the patient to a course of treatment, 1 day examination after the course of treatment, 18 days treatment with internal and external use of the CA, including drinking water treatment daily for 18 days, duodenal drainage with the CA - 3 treatments, colonic irrigation alternates with toning baths and is 5 treatments irrigation and 10 procedures baths. In addition, disposable drinking dose armature with a temperature of 36-38°C gradually increases from 50-80 ml to 200 ml, treatment of duodenal drainage is AMBA, preheated to a temperature of 37-39°C in a volume of 200 ml single dose treatment of intestinal irrigation is applied armature, preheated to a temperature of 39-40°C, while single dose of 500 ml with a subsequent increase to 800 ml.

Comparative analysis of the characteristics of the claimed solution with signs prototype demonstrates compliance of the claimed solution to the criterion "novelty".

Signs of a distinctive part of the formula of the invention provide improved treatment of irritable bowel syndrome with constipation, long-term remission, humanistically recurrence and prevent the development of inflammatory processes in the intestinal mucosa.

Mineral water "Abalaka" due to the high content of bicarbonate ions (HCO3) plays an important role in maintaining acid-alkaline (basic) balance, normalization of the secretory and motor functions of the stomach, biliary tract and intestines, has a pronounced anti-inflammatory effect.

The proposed method is as follows.

When irritable bowel syndrome with constipation the patient 21-day comprehensive treatment, including daily 3-course drinking armature with a temperature of 36-38°C for 18 days, with a gradual increase in dose with 50-80 ml to 200 ml, 3 procedures duodenal drainage CA (200 ml), the temperature of 37-39°C, 10 procedures coniferous or RPMA baths, the temperature of 36-37°C with a duration of 12-15 minutes. In alternation with baths is colonic irrigation armature, the temperature To 39-40°C, followed by an increase of a single dose of CA from 500 to 800 ml, treatment 5 treatments.

Drinking armature is assigned the first two days 50-80 ml 3 times a day, for 3-4 day single dose of water is increased to 100 ml, 5-6 days - 150 ml from 7 days single dose taken water increases up to one Cup (200 ml). Method and time of reception of the armature is determined by the condition of the secretory function of the stomach. Water take gulps with a delay at the root of language medl the NGOs, slowly: for 15-30 minutes before meals with reduced gastric secretion, for 40-45 minutes before meals with retained secretions, for 1-1,5 hour before meals with increased secretion.

The results of the treatment were evaluated by clinical, laboratory and instrumental diagnostic methods.

The proposed method treated 10 patients with irritable bowel syndrome with constipation, 7 men and 3 women aged 32-53 years.

The diagnosis is verified on the basis of complaints, anamnesis, physical examination, clinical laboratory, instrumental and functional diagnostic methods. Acid-forming function of the stomach was determined by gastric intubation with stimulation limonera. By rektoromanoskopii and colonoscopy were surveyed intestines were conducted fractional duodenal intubation with microscopy of bile. The patients were examined in the dynamics before and after the course of treatment. After carrying out a course of treatment proposed method showed a significant improvement in General condition and well-being of all patients and decreased time delay stomach emptying.

The proposed method is illustrated by the following clinical examples.

Example 1. Patient P., 53, health card number 16 has been treated with a diagnosis of irritable bowel syndrome with constipation. Is the and the dispensary since 2003. In the study of acid-forming function of the stomach revealed hipocresia. Complaints of bloating, constipation for 3-4 days.

On the background of complex treatment of the patient within 18 days of taking armature temperature of 36-38°C for 30 minutes before a meal, slowly, slowly gulps 3 times a day for 50-80 ml during the first two days. Single dose of CA 3-4 days of treatment was 100 ml, 5-6 days 150 ml.

Starting with a 7 day, single dose taken water increased to one glass of 200 ml Treatment consisted of 3 treatments duodenal drainage CA (200 ml) temperature of 37-39°C, 5 treatments of intestinal irrigation armature temperature To 39-40°C after enemas, followed by an increase of a single dose of CA 500 ml to 800 ml Colonic irrigation alternated with RPMA bath temperature of 36-37°C. For a treatment course of 10 treatments : baths lasting 12-15 minutes. After a three-week course of treatment, the patient noted an independent chair 1 time per day.

Example 2. Patient A., aged 35, medical card No. 55, was treated with a diagnosis of irritable bowel syndrome with constipation. When examination revealed normal acid-forming function of the stomach. Complaints of bloating, a feeling of heaviness in the epigastrium, constipation for 4-5 days.

The treatment was carried out in accordance with the claimed method. After the examination, the patient is assigned to drinking cured the e armature within 18 days the temperature of 36-38°C. the Recommended 3-time reception armature 45 minutes before eating large SIPS slowly, 50-80 ml during the first two days. Single dose of CA 3-4 days of treatment was 100 ml, 5-6 days - 150 ml from 7 days single dose taken water increased to one glass of 200 ml of Duodenal drainage warm (37-39°C) mineral water "Abalaka" (200 ml), 3 treatments on the course of treatment. Bath coniferous 10 treatments a day, a temperature of 36-37°C, with a duration of 12-15 minutes. Colonic irrigation armature from 500 to 800 ml, the temperature To 39-40°C, 5 treatments after cleansing enema in alternation with baths. The course of treatment is 21 days.

Treatment the patient underwent good clinical manifestations of balneology not identified. After the treatment has greatly improved the health of the patient, controlled completely dyspeptic syndromes, decreased time delay stomach emptying up to two days.

Thus, therapeutic properties of the CA can be used in gastroenterology and balneology, in particular, in the treatment of irritable bowel syndrome with constipation. In addition, the invention is directed to expanding the range of therapeutic mineral waters through the use of local mineral waters in the immediate vicinity of the source.

A method of treating irritable bowel syndrome with constipation is the use of mineralized sodium bicarbonate mineral water "Abalaka (CA) with a slightly alkaline reaction of the aquatic environment, including thrice daily drinking of CA, duodenal drainage using CA, procedures, intestinal irrigation with the use of CA after enemas, procedures tonic coniferous or RPMA baths; the course of complex treatment is 21 days, including drinking -18 days, one drinking dose armature temperature of 36-38°C gradually increases from 50-80 ml to 200 ml, treatment of duodenal drainage is used armature temperature of 37-39°C in a volume of 200 ml single dose treatment of intestinal irrigation armature is preheated up to 39-40°C, and single dose of 500 ml with increasing to 800 ml, procedures, intestinal irrigation, alternate baths.



 

Same patents:

FIELD: medicine.

SUBSTANCE: invention refers to medicine and aims at treating bile passage dysfunction. What is involved is a 2-staged integrated treatment. At the 1st stage, a diet, sorbents, mineral water, physiotherapy (thermal vibromassage of the area of the gall bladder and liver, or biologically active points) are prescribed. At the 2nd stage, the treatment is prolonged by administering adsorbents in the form of herbal preparations, as well as pelotherapy considering a type of dysfunction.

EFFECT: method enables reducing the length of pain management, prolonging remission or achieving full rehabilitation in children and adolescents suffering bile passage dysfunction and living in environmentally unfriendly regions.

3 cl, 4 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, and may be used for treating septic wounds and burns. A composition possessing antibacterial action contains active metal biocomplexes with 5-nitroimidazole and β-pyridine carboxylic acid and a base providing a soft dosage form. As a gelling agent, there may be used modified cellulose derivatives, additionally comprising methyl monosilane hydrogel (enterosgel) and/or polyvinylpyrrolidone, or an alloy of polyethylene oxide-400 and polyethylene oxide-1500. As a mixture of hydrophilic substances, the base contains substances specified in a group of: polyethylene oxides, dimexide, glycerol and aerosol, may comprise at least one target additive of: anaesthetic - trimecaine, pyrromecaine, lidocaine, or a mixture thereof, a repair process stimulator - methyluracil, acemine, solcoseryl, Spirulina microalgae (Spirulina platensis), or a mixture thereof, antiseptic - miramistine, chlorhexidine digluconate, dioxidine or a mixture thereof. The composition is presented in the form of an ointment or gel.

EFFECT: invention provides the improved microcirculation in wound tissues, as well as anti-inflammatory action, repair process stimulation.

5 cl, 6 tbl, 4 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, and concerns a combined pharmaceutical composition for treating skin diseases. The composition contains betamethasone, preferentially betamethasone dipropionate, urea and at least one adjuvant. As adjuvants, the composition contains a hydrophobic component, an emulsifier, a preserving agent, a buffer agent, a non-aqueous solvent and water. A method for preparing the declared composition consists in the fact that the melted hydrophobic component, emulsifier and water are emulsified, and then betamethasone and the preserving agent are introduced at temperature below 60°C, homogenised and added with a prepared solution of urea and the buffer agent.

EFFECT: pharmaceutical composition is characterised by high pharmacological activity, stability, uniform distribution of the active ingredients.

7 cl, 8 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to urology and may be used for treating category II chronic prostatitis and erectile dysfunction. For this purpose, alpha 1 adrenoceptor blocking agents are prescribed with underlying antibiotics. That is combined with pneumovibromassage of the prostate and pulse vacuum fallostimulation. Besides, there are prescribed prostatilen 5 mg once a day intramuscularly for 10 days and Cytoflavinum in therapeutic dosages: 10.0 or 20.0 in 200.0 or 400.0 ml of 0.9% normal saline intravenously drop-by-drop once a day for 10 days. Then, the scheme provides 2 tablets 2 times a day for 20 days.

EFFECT: method provides the substantially increased clinical effectiveness and reduced length of treatment with no side effects.

1 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely andrology, as well as may be used in veterinary science for treating mammals suffering disturbed fertility. An agent for improving the reproductive function represents a clathrate complex of γ-cyclodextrin and arabinogalactan, or glycyrrhetinic acid with 9-phenyl-symmetrical octahydroselenoxantene in the α-crystalline form and is described by structural with Cu-K emitted X-ray powder pattern having characteristic reflections expressed in degrees of diffraction angle 2θ: 6.0 12.0 15.0 17.0 19.0 20.0 21.5, 21.7, 20.9 25.0 27.0 28.0 29.0 37.0 and a melting point of 96.8°C.

EFFECT: improved pregnancy and fertility rates.

18 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely dentistry, and may be used for local therapy of inflammatory periodontal diseases. That is ensured by the daily applications of powdered cellulose surgical cotton on a dentogingival edge after curettage to normalise the microcirculation and hemodynamic values.

EFFECT: method provides higher clinical effectiveness in periodontal diseases, reduced complications and disability periods due to normalising the free radical levels in the damaged tissue while reducing inflammation and accelerating the process of epithelialisation of periodontal tissues.

2 ex

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to urology, and can be used for treatment of benign hyperplasia of prostate gland. For this purpose dynamic examination of prostate gland is carried out before drug therapy and 3, 6 and 9 months after that. Dynamic examination includes transrectal ultrasound examination (TRUSE) with Dopplerography and sonoelastography (SEG) of prostate gland. Comparison of prostate size values, hyperplasia size, blood flow in capsular and parauretral arteries, blood flow in adenomatous nodes and density of transitory zones of prostate is carried out in SEG. If values of examined parameters by TRUSE data decrease by 15% and more, each parameter is given 1 point. If density of transitory zones of prostate in sonoelastography is higher than 35 KPa, 1 point is given too. As a result if the sum is not less than 4 points, conservative therapy is stopped. If the sum of points is less than 4 points, therapy is continued. Examination is repeated after next 3 months.

EFFECT: method ensures reduction of terms of drug treatment and increase of treatment quality due to possibility of determining indications for complete or partial cancellation of drug treatment within 3-6 months.

1 tbl, 3 ex

FIELD: chemistry.

SUBSTANCE: present invention relates to organic chemistry and specifically to novel 2,5-dioxo-imidazolidine derivatives of general formula lb , or pharmaceutically acceptable salts and solvates thereof, or solvates of pharmaceutically acceptable salts, where X denotes O; R1 is H; or R1 is selected from C1-C6 alkyl and C1-C6 alkynyl, where the alkyl can optionally be substituted with a cyano group; R2a is selected from H, P(O)(OH)2 and C(O)(CH2)n1C(O)OH; or R2a is selected from -C(O)-C1-C6 alkyl, which is substituted with amino; n1 equals 1 or 2; each R2 and Rc is independently selected from H and C1-C6 alkyl; R3a is H, a halogen atom or cyano; each R3b is independently a halogen atom or cyano; or each R3b is independently C1-C6 alkyl, optionally substituted with three halogen atoms; each R4a and R4b is independently H or a halogen atom; or each R4a and R4b is selected from C1-C6 alkyl, and C1-C6 alkoxy, where the alkyl is substituted with three halogen atoms; R4c is a halogen atom or cyano; and ml equals 0 or 1. The invention also relates to a pharmaceutical composition based on a compound of formula lb and use thereof.

EFFECT: obtaining novel 2,5-dioxo-imidazolidine derivative which modulate androgen receptor activity.

20 cl, 5 tbl, 31 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmacy, medicine and veterinary science, particularly new drugs for inflammatory and allergic diseases. The assigned problem preparing a non-toxic, easy-to-use and storage-stable drug in the form of eye drops, intranasal drops and spray and causing anti-inflammatory and antiallergic action is solved by creating a composition containing a pigment-mineral complex of sea-urchin shell (0.05-2.0%) containing spinochromes B, D, dimer polyhydroxynaphthoquinone and a mineral ingredient (calcium, magnesium, phosphor, sodium, potassium) in the form of water-soluble salts, a co-solvent (0.01-10%), a preserving agent (0.01-0.2%), an antioxidant (0.01-0.2%), an acidity regulator (to pH 6.0-8.0) and water (to 100%).

EFFECT: what is described is the experimentally specified method for preparing the agent according to the invention eliminating the oxidation of the pigment-mineral complex as early as the stage of preparing.

3 cl, 3 tbl, 1 dwg, 6 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine. What is presented is a method of treating chronic adenoiditis in children. A real-time polymerase chain reaction is used to analyse the blood serum concentrations of interleukine-1β and interleukine-4. Observing the C/C genotype of interleukine-1β gene in locus 3954 in a combination with the C/C or C/T genotype of interleukine-4 gene in locus 589 enables diagnosing a severe clinical course of chronic adenoiditis with frequent aggravations, complications requiring the treatment including intranasal inhalations of the suspension of mometasone 50-100 mcg per a procedure into each nasal passage 1-2 times a day 100-400 mcg daily for 30 days. Observing the C/T genotype of interleukine-1β gene in locus 3954 in a combination with the C/C or C/T genotype of interleukine-4 gene in locus 589 enables diagnosing a moderate severity of chronic adenoiditis with aggravated recurrences that requires the treatment including intranasal inhalations of the suspension of mometasone 50 mcg per a procedure into each nasal passage 1 time a day 100 mcg daily for 21-30 days. Observing the T/T genotype of interleukine-1β gene in locus 3954 in a combination with the C/C or C/T genotype of interleukine-4 gene in locus 589 enables diagnosing a mild severity of chronic adenoiditis with a mild clinical course and a favourable outcome, treated by intranasal lyophilised interleukine-1β in physiological solution 5-10 ng/ml per a procedure into each nasal passage once a day with a daily dose to be increased by 5-10 ng/ml every 1-2 days, but no more than 30 ng/ml for 5-16 days.

EFFECT: invention provides stratifying the risk groups with chronic adenoiditis and provides the effective method of treating chronic adenoiditis in children.

8 dwg, 3 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine and aims at treating bile passage dysfunction. What is involved is a 2-staged integrated treatment. At the 1st stage, a diet, sorbents, mineral water, physiotherapy (thermal vibromassage of the area of the gall bladder and liver, or biologically active points) are prescribed. At the 2nd stage, the treatment is prolonged by administering adsorbents in the form of herbal preparations, as well as pelotherapy considering a type of dysfunction.

EFFECT: method enables reducing the length of pain management, prolonging remission or achieving full rehabilitation in children and adolescents suffering bile passage dysfunction and living in environmentally unfriendly regions.

3 cl, 4 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to physiotherapy, gastroenterology. The method involves dietary therapy No. 5, general pine baths, magnetic laser therapy, intake of mineral water with underlying sparing training regimen followed by transverse galvanisation of the epigastrial area. The transverse galvanisation immediately follows the intake of mineral water between 10 to 11 o'clock. Additionally, the right hypochondrium and sternum are exposed to EHF radiation generated by a broadband noise transducer with a frequency of 40-63 GHz, for 10 minutes per each area, every day; the therapeutic course is 10-12 procedures.

EFFECT: method enables higher clinical effectiveness ensured by using a chronobiological approach to treating the patients for the purpose of relieving the functional disorders of the bile system with underlying increased adaptive capacities of the body.

2 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely - to dermatology, physiotherapy. The method includes taking mineral baths with mineral water of Annensk deposit of the Khabarovsk Territory and joint mud therapy. Additional, the patient intakes mineral water 100 - 200 ml, 3 times a day 30 minutes before meals. The baths are taken once a day at temperature 37 - 38°C, for 10-20 minutes. The therapeutic course includes 10-14 baths. The joint mud therapy is performed by applying low-mineralised low-sulphide silt mud on the affected joints. The mud therapy is performed two days running with a one-day pause. The therapeutic course is 6-10 procedures. After the therapeutic course is completed, the affected joints are coated with Relyct gel for 1.0 - 1.5 months dissolved in mineral water.

EFFECT: method prolongs the length of the intercurrent period.

3 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely balneology, physiotherapy. A method involves intake of mineral water, bath taking, small herbal enemas, mineral water siphonages and thermotherapy. Low-mineral carbonate hydrocarbonate-sulphate sodium-calcium mineral water 3.6-3.7 g/l is taken in the amount of 3-5 ml per one kg of body weight 3 times a day 40-45 minute before meals. Same mineral water is used for bath taking at temperature 36-37°C for 15 minutes, 8 procedures every second day. Small herbal enemas are prescribed every second day; the therapeutic course is 8 procedures. Mineral water siphonages are prescribed in number of 3-4 procedures within the therapeutic course. The thermal therapy includes preventative mini-sauna "Cedar Spa" every second day within the therapeutic course of 10 procedures.

EFFECT: method provides higher clinical effectiveness ensured by relieving manifestations of metabolic syndrome, increasing a testosterone level, normalising lipid metabolism.

3 ex, 2 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, and aims at treating irritable bowel syndrome. What is used is a low-mineralised sodium hydrocarbonate Abalakhskaya mineral water (AMW) with an faintly alkaline reaction of aqueous medium. The complex therapeutic course makes 21 days including drinking therapy - 18 days, a single drinking dose of AMW of temperature 38-40°C is gradually increased from 50-80 ml to 180-200 ml; the procedures of duodenal drainage are performed with the use of AMW of temperature 37-38°C in the amount of 200 ml of a single dose; for the procedures of intestinal irrigations, AMW is pre-heated to 40-42°C, while a single dose makes 500 ml gradually increased to 800 ml; the procedures of intestinal irrigations are alternated with baths.

EFFECT: method provides higher clinical effectiveness in irritable bowel syndrome, normalised intestinal motility.

2 ex

FIELD: medicine.

SUBSTANCE: invention relates to medicine, gastroenterology. Method includes dietotherapy in accordance with diet No 5, exercise therapy. Additionally intake of low-mineralised carbonaceous chloride-hydrocarbonate-sulfate-sodium-calcium mineral water "Essentuki-Novaya" is realised. Water is taken in in dose 3.5 ml per 1 kg of patient's body weight, 3 times per day, 30-40 minutes before meal. Carbonaceous-hydrogen sulfide mineral baths with content of hydrogen sulfide 15-20 mg/l are carried out every second day. Baths are taken with water temperature 36-37°C. Course includes 8-10 procedures. Dalargin magnetophoresis on liver projection is performed daily. Pulsing travelling magnetic field from apparatus AMO-ATOS is used. Magnetophoresis is carried out with induction 45 mT, with modulation frequency 10 Hz for 15 minutes, course includes 10 procedures.

EFFECT: method reduces treatment terms and increases its efficiency due to normalisation of oxidative homeostasis, improvement of functional state of liver and lipid metabolism.

2 ex, 4 tbl

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to balneology. Method includes taking baths with mineral water of thermal radon springs with water temperature about 38°C. Baths are taken two days running with a day break after them. The first procedure lasts 3 minutes, the second procedure lasts 5 minutes. The following procedures last 8 minutes. Treatment is carried out at the background No 8 diet. Patient drinks 100 ml of radon water in the first part of the day, two hours after breakfast. Swimming in a swimming pool is performed for 40 minutes. After that detensor-therapy is carries out. In the second half of the day patient drinks 100 ml of radon water two hours after dinner, then takes a bath with radon water. After that, procedure by programme of resonance-acoustic fluctuations (PRAF) is carried out, followed by swimming in a swimming pool for 40 minutes. On days when there are no baths intestinal lavage is performed in the first half of the day, with 40-minute long swimming in a swimming pool in the second half.

EFFECT: method increases treatment efficiency due to complex impact on organism, providing improvement of tissue trophism, microcirculation, metabolism in affected extremities, increasing tone in lymphatic vessels, improving lymph outflow.

3 cl, 2 tbl

FIELD: medicine.

SUBSTANCE: formulation for treating patients with urolithiasis which contains an active ingredient presented by a mixture of saturated and unsaturated aliphatic hydrocarbons C10-C24 recovered from mineral water of Munok pool situated in Kazachinskiy-Lenskiy area of the Irkutsk Region (source No. 17), a stabilising agent - ethanol and water in certain qualitative and quantitative proportions.

EFFECT: formulation is effective for treating urolithiasis.

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to balneology. Method includes complex treatment of patients. First, patient's individual sensitivity to radon procedures is estimated. For this purpose arterial pressure and heart rate are measured before bath. After that, patient takes a bath with mineral water of thermal radon springs with natural water temperature of about 38°C, rests for 30 minutes. Arterial pressure and heart rate are re-measured. If heart rate does not change, or changes by 10 beats/minute, and systolic and/or diastolic arterial pressure changes by ±10 mm Hg, I type of reaction is determined in patient. If heart rate changes by ± 20 beats/minute, and systolic and/or diastolic arterial pressure changes by ±15 mm Hg, II type of reaction is determined in patient. If heart rate changes by ± 30 beats/minute, and systolic and/or diastolic arterial pressure changes by ±20 mm Hg, III type of reaction is determined in patient. In case of I type reaction, bath with radon water is taken according to the following scheme: first procedure - 5 minutes, second procedure - 8 minutes, third procedure - 10 minutes, the following procedures - 15 minutes. In case of type II reaction bath with radon water is taken according to the following scheme: first procedure - 5 minutes, second procedure - 8 minutes, third procedure - 10 minutes, all following procedures - 15 minutes. In case of type III reaction bath with radon water is taken according to the following scheme: first procedure - 3 minutes, second procedure - 5 minutes, third procedure - 8 minutes, all following procedures - 10 minutes, bath with radon water general or local with submergence of legs into water, or four-chambered. Baths are taken for two days every day, then follows a day break. Treatment is performed at the background of No 6 diet. In the first half of the day, two hours after breakfast patient drinks 200 ml of radon water in sips at a measured pace. After that, mud applications on the area of feet and lower third of shins are performed. Detensor-therapy is carried out. In the second half of the day, two hours after dinner patient drinks 200 ml of radon water in swallows at a measured pace. After that, patient takes a bath with radon water. After bath procedure in accordance with programme of resonance-acoustic fluctuations (PRAF) is performed. On the days when baths are not taken, in the first half of the day intestinal lavage is performed. In the second half of the day mini-sauna "Cedar burrel" with products of antler deer-breeding is carried out.

EFFECT: method increases treatment efficiency due to reduction of uric acid, improvement of joint mobility.

3 cl, 2 tbl

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to therapy, physiotherapy, balneology. Method includes carrying out respiratory gymnastics, inhalations with mineral water, manual massage of chest, applications of peloids, electric stimulation at the background of drug basic therapy. During electric stimulation impact is performed by high-amplitude pulse current with biological feedback, with frequency 90-100 Hz and gradually increasing current intensity until sensation of painless vibration appears. On the first day impact is performed paravertebrally at the level D1-D7 and along 7-8 intercostal spaces. On the second day impact is performed paravertebrally and on collar area. Peloid therapy is carried out 20-30 minutes after electric stimulation. In first application impact is performed on chest at temperature 38-40°C and 20-30 minute exposure. On the second day of application impact is performed on collar area at temperature 35-36°C. Course of treatment includes 6-7 coupled impacts on each zone.

EFFECT: method increases treatment efficiency and increases remission duration due to expressed local and systemic anti-inflammatory effect.

2 tbl, 2 ex

FIELD: medicinal microbiology, medicine, pharmacy.

SUBSTANCE: invention relates to agents used for enhancing sensitivity of microorganisms to antibacterial preparations. Invention involves applying hydrocarbonate chloride-sodium drinking mineral water "Obukhovskaya" with the total mineralization 1.8-2.2 g/l as an agent for enhancing sensitivity of microorganisms to antibacterial preparations that is used early for treatment of atopic dermatitis and as an agent for treatment of iodine-deficient states. It has been found by method using disks that mineral water "Obukhovskaya" provides enhancing sensitivity of microorganisms to such antibacterial preparations as antibiotics and specific preparations against yeast-like fungi.

EFFECT: improved and valuable agent.

6 tbl, 6 ex

Up!